With the analysis among 339 patents, we discovered top 125 key players by total patent application. Yungjin Pharm. Co., Ltd., Korea Research Institute of Bioscience & Biotechnlogy, R.P. Scherer GmbH & Co. KG are dominant in this area. They take 24.78% of the total patent filing.
Korea Research Institute of Bioscience & Biotechnlogy
R.P. Scherer GmbH & Co. KG
Tokyo-to, Japan
Patent: 19
Suzhou Proda Biotechnology Co., Ltd.
Jiangsu Sheng, China
Patent: 18
Thesan Pharmaceuticals, Inc.
California, United States
Patent: 12
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 6
Baxter International, Inc.
Illinois, United States
Patent: 5
With the analysis among 5 patents, we discovered top 3 start-ups by total patent application.
Louisiana, United States
Patent: 2
North Carolina, United States
Patent: 2
Institut National de la Santé et de la Recherche Médicale
With the analysis among related 125 patents applied in the last 5 years. We discover 71 most active companies in this area. The fast-growing Regeneron Pharmaceuticals, Inc., Eberhard Karls Universität Tübingen, German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) take 10.40% of patent filing during this period.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 6
Eberhard Karls Universität Tübingen
Baden-Württemberg, Germany
Patent: 4
German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 2
Nanjing Anji Biological Technology Co Ltd
Jiangsu Sheng, China
Patent: 2
North Carolina State University
North Carolina, United States
Patent: 2
Louisiana, United States
Patent: 2
Wuhan Institute of Physics and Mathematics, Chinese Academy of Sciences
undefined undefined
Patent: 2
Hunan Sheng, China
Patent: 2
West China Hospital of Sichuan University
With the analysis among related 125 patents in last 5 years, we discover 58 new entrants. Regeneron Pharmaceuticals, Inc., Eberhard Karls Universität Tübingen, German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) are the most active new entrants in this area.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 6
Eberhard Karls Universität Tübingen
Baden-Württemberg, Germany
Patent: 4
German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)
Nanjing Anji Biological Technology Co Ltd
Jiangsu Sheng, China
Patent: 2
North Carolina State University
North Carolina, United States
Patent: 2
Louisiana, United States
Patent: 2
Wuhan Institute of Physics and Mathematics, Chinese Academy of Sciences
undefined undefined
Patent: 2
Hunan Sheng, China
Patent: 2
West China Hospital of Sichuan University
Northeast Agricultural University
Heilongjiang Sheng, China
Patent: 2
With the analysis among 237 patents, we discovered top 82 universities and scientific research institutions by total patent application. China Pharmaceutical University, The Trustees of Columbia University in The City of New York, Peking University are dominant in this area. They take 30.38% of the total patent filing.
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 8
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 6
Beijing Shi, China
Patent: 5
Jiangsu Sheng, China
Patent: 5
Council of Scientific & Industrial Research
Eberhard Karls Universität Tübingen
Baden-Württemberg, Germany
Patent: 4
China Agricultural University
Beijing Shi, China
Patent: 4
Shanghai Institute of Pharmaceutical Industry
Shanghai Shi, China
Patent: 4
Shanxi Sheng, China
Patent: 3